Page last updated: 2024-10-28

hexamethylene bisacetamide and Plasmacytoma

hexamethylene bisacetamide has been researched along with Plasmacytoma in 1 studies

N,N'-diacetyl-1,6-diaminohexane: chemical name obtained from Acta Biol Hung 1990;41(1-3):199-208

Plasmacytoma: Any discrete, presumably solitary, mass of neoplastic PLASMA CELLS either in BONE MARROW or various extramedullary sites.

Research Excerpts

ExcerptRelevanceReference
"We find that induction of mouse erythroleukemia cell differentiation with either dimethylsulfoxide (DMSO) or hexamethylene bisacetamide (HMBA) leads to increased expression of Rb mRNA."1.28Increased retinoblastoma gene expression is associated with late stages of differentiation in many different cell types. ( Cole, MD; Coppola, JA; Lewis, BA, 1990)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Coppola, JA1
Lewis, BA1
Cole, MD1

Other Studies

1 other study available for hexamethylene bisacetamide and Plasmacytoma

ArticleYear
Increased retinoblastoma gene expression is associated with late stages of differentiation in many different cell types.
    Oncogene, 1990, Volume: 5, Issue:11

    Topics: Acetamides; Animals; B-Lymphocytes; Cell Differentiation; Dimethyl Sulfoxide; Embryo, Mammalian; Gen

1990